Carbapenem resistance in Acinetobacter baumannii:: mechanisms and epidemiology

被引:872
作者
Poirel, L. [1 ]
Nordmann, P. [1 ]
机构
[1] Univ Paris 11, S Paris Med Sch, Hop Bicetre, Serv Bacteriol Virol, F-94275 Le Kremlin Bicetre, France
关键词
Acinetobacter baumannii; carbapenems; metallo-beta-lactamase; oxacillinase; resistance; review;
D O I
10.1111/j.1469-0691.2006.01456.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The increasing trend of carbapenem resistance in Acinetobacter baumannii worldwide is a concern since it limits drastically the range of therapeutic alternatives. Metallo-beta-lactamases (VIM, IMP, SIM) have been reported worldwide, especially in Asia and western Europe, and confer resistance to all beta-lactams except aztreonam. The most widespread beta-lactamases with carbapenemase activity in A. baumannii are carbapenem-hydrolysing class D beta-lactamases (CHDLs) that are mostly specific for this species. These enzymes belong to three unrelated groups of clavulanic acid-resistant beta-lactamases, represented by OXA-23, OXA-24 and OXA-58, that can be either plasmid- or chromosomally-encoded. A. baumannii also possesses an intrinsic carbapenem-hydrolysing oxacillinase, the expression of which may vary, that may play a role in carbapenem resistance. In addition to beta-lactamases, carbapenem resistance in A. baumannii may also result from porin or penicillin-binding protein modifications. Several porins, including the 33-kDa CarO protein, that constitute a pore channel for influx of carbapenems, might be involved in carbapenem resistance.
引用
收藏
页码:826 / 836
页数:11
相关论文
共 80 条
[21]   Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates [J].
Da Silva, GJ ;
Leitao, R ;
Peixe, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :2109-2110
[22]  
Da Silva GJ, 2002, FEMS MICROBIOL LETT, V215, P33, DOI 10.1111/j.1574-6968.2002.tb11366.x
[23]   Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula [J].
Da Silva, GJ ;
Quinteira, S ;
Bértolo, E ;
Sousa, JC ;
Gallego, L ;
Duarte, A ;
Peixe, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :255-258
[24]   Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil [J].
Dalla-Costa, LM ;
Coelho, JM ;
Souza, HAPHM ;
Castro, MES ;
Stier, CJN ;
Bragagnolo, KL ;
Rea-Neto, A ;
Penteado, SR ;
Livermore, DM ;
Woodford, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) :3403-3406
[25]   Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii [J].
Fernández-Cuenca, F ;
Martínez-Martínez, L ;
Conejo, MC ;
Ayala, JA ;
Perea, EJ ;
Pascual, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :565-574
[26]   Comparative genomics of multidrug resistance in Acinetobacter baumannii [J].
Fournier, Pierre-Edouard ;
Vallenet, David ;
Barbe, Valerie ;
Audic, Stephane ;
Ogata, Hiroyuki ;
Poirel, Laurent ;
Richet, Herve ;
Robert, Catherine ;
Mangenot, Sophie ;
Abergel, Chantal ;
Nordmann, Patrice ;
Weissenbach, Jean ;
Raoult, Didier ;
Claverie, Jean-Michel .
PLOS GENETICS, 2006, 2 (01) :62-72
[27]   Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital [J].
Gales, AC ;
Tognim, MCB ;
Reis, AO ;
Jones, RN ;
Sader, HS .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (01) :77-79
[28]   IMIPENEM RESISTANCE IN ACINETOBACTER-BAUMANNII IS DUE TO ALTERED PENICILLIN-BINDING PROTEINS [J].
GEHRLEIN, M ;
LEYING, H ;
CULLMANN, W ;
WENDT, S ;
OPFERKUCH, W .
CHEMOTHERAPY, 1991, 37 (06) :405-412
[29]   Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa [J].
Girlich, D ;
Naas, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2043-2048
[30]   Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii [J].
Héritier, C ;
Poirel, L ;
Nordmann, P .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (02) :123-130